I3C treatment significantly inhibited the WWPI overexpression and its mediated upregulation of KLF15-ubiquitination, p65 acylation, and MAPK-induced inflammation in MI [172], suggesting that I3C could be a potential cardioprotective agent against MI. Here, KLF15 is linked to myocardial infarction.